Category: Microbiology & Virology
Global Microbiology & Virology
-
Industrial Microbiology
... CAGR of 4.6% over the analysis period 2024-2030. Pharmaceuticals End-Use, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$11.6 Billion by the end of the analysis ... Read More
-
Sepsis Diagnostics
... CAGR of 7.5% over the analysis period 2024-2030. Microbiology Technology, one of the segments analyzed in the report, is expected to record a 9.1% CAGR and reach US$749.8 Million by the end of the analysis ... Read More
-
Pneumonia Testing
... CAGR of 6.2% over the analysis period 2024-2030. Immunodiagnostics, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$339.9 Million by the end of the analysis period. ... Read More
-
Cervical Dysplasia Diagnostics
... at a CAGR of 5.9% over the analysis period 2024-2030. Diagnostic Tests, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$793.8 Million by the end of ... Read More
-
Zika Virus Testing
... at a CAGR of 5.8% over the analysis period 2024-2030. Molecular Testing, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$192.4 Million by the end of ... Read More
-
Legionella Testing
... CAGR of 8.2% over the analysis period 2024-2030. Culture Methods, one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$122.4 Million by the end of the analysis ... Read More
-
Poultry Diagnostics
... CAGR of 9.0% over the analysis period 2024-2030. ELISATest, one of the segments analyzed in the report, is expected to record a 9.9% CAGR and reach US$558.3 Million by the end of the analysis period. ... Read More
-
Dengue Testing
... CAGR of 4.8% over the analysis period 2024-2030. ELISA-Based Tests, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$383.2 Million by the end of the analysis ... Read More
-
Herpes Marker Testing
... at a CAGR of 4.9% over the analysis period 2024-2030. Antibody / Antigen-Based Kits, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$332.9 Million by the ... Read More
-
Cervical Cancer Diagnostic Testing
... 2030, growing at a CAGR of 5.1% over the analysis period 2024-2030. Pap Smear Test, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$5.3 Billion by ... Read More
-
Enteric Disease Testing Global Market Report 2025
... market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective ... Read More
-
Global Syphilis Rapid Test Kit Competitive Landscape Professional Research Report 2025
... causes syphilis. This kit typically contains all the necessary components for conducting a simple and quick test, including test cassettes, sample collection swabs or lancets, buffer solutions, and instructions for use. The test works by ... Read More
-
Precision Diagnostics & Medicine Market by Diagnostic Testing (Genetic, DTC), Diagnostics Indication (Oncology, Neurology, Immunology), Therapeutic Products (Inhibitors, mAbs, CGT), Indication (Oncology, Rare Disease, Infectious) - Global Forecast to 2029
... Medicine market is projected to reach USD 246.66 billion in 2029 from USD 145.53 billion by 2024, at a CAGR of 11.1% during the forecast period. Factors such as the ongoing integration of advanced technologies ... Read More
-
2025 Global: E.Coli Testing - Innovative Markets Forecast (2031) report
... based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2020 to 2031 using regression analysis in our modeling. and Perry/Hope is the only market research publisher ... Read More
-
2025 Global: Enteric Disease Testing Market - Innovative Markets Forecast (2031) report
... industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2020 to 2031 using regression analysis in our modeling. and Perry/Hope is the only market ... Read More
-
Global Human Hepatitis B Immunoglobulin (HBIG) Market Growth 2025-2031
... to grow at a CAGR of %from 2025 to 2031. United States market for Human Hepatitis B Immunoglobulin (HBIG) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a ... Read More
-
PEGylated Proteins Market Report by Product (Consumables, Services), Protein Type (Colony Stimulating Factors, Interferons, Erythropoietin, mAbs, Recombinant Factor VII, and Others), Application (Cancer Treatment, Hepatitis, Chronic Kidney Diseases, Hemophilia, Multiple Sclerosis, Gastrointestinal Disorders, and Others), End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic and Research Institutes), and Region 2025-2033
... End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic and Research Institutes), and Region 2025-2033 The global PEGylated proteins market size reached USD 1.4 Billion in 2024. Looking forward, IMARC Group expects the market ... Read More
-
Syphilis Testing Market by Type (Primary and Secondary Syphilis, Latent and Tertiary Syphilis), Location of Testing (Laboratory Testing, Point-of-Care (POC) Testing), and Region 2025-2033
... 2024. Looking forward, IMARC Group expects the market to reach USD 2.0 Billion by 2033, exhibiting a growth rate (CAGR) of 4.9% during 2025-2033. The growing prevalence of sexually transmitted diseases (STDs), the increasing incidences ... Read More
-
Companion Animal Diagnostics Market by Product (Consumables, Instruments), Technology (Clinical Biochemistry, Hematology), Application (Clinical Pathology, Virology), Animal (Dogs, Cats, Horses), End User (Diagnostic Laboratories) - Global Forecast to 2029
... projected to reach USD 4.55 Billion by 2029 from USD 2.99 Billion in 2024 at a CAGR of 8.8% during the forecast period. Favorable laws and ever-present availability of animal insurance, with more animals getting ... Read More
-
Hepatitis B Virus Drug Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Product Type
... and its CAGR from 2020 to 2024, and also forecasts its market size to the end of 2030 and its CAGR from 2025 to 2030. For geography segment, regional supply, demand, major players, price is ... Read More
-
Global Molecular Diagnostics in Infectious Disease Testing Market 2024 by Company, Regions, Type and Application, Forecast to 2030
... size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period. Molecular diagnostics is a technique used to ... Read More
-
Global Syphilis Immunoassay Diagnostics Market 2024 by Company, Regions, Type and Application, Forecast to 2030
... in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period. Syphilis is a sexually transmitted disease caused by a bacterium called treponema pallidum. ... Read More
-
Global Molecular Diagnostics in Infectious Disease Testing Market Growth (Status and Outlook) 2024-2030
... million in 2023. With growing demand in downstream market, the Molecular Diagnostics in Infectious Disease Testing is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. ... Read More
-
Global Syphilis Immunoassay Diagnostics Market Growth (Status and Outlook) 2024-2030
... in downstream market, the Syphilis Immunoassay Diagnostics is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the ... Read More
-
Global Syphilis Diagnosis Market 2024 by Company, Regions, Type and Application, Forecast to 2030
... and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period. Syphilis is a chronic, systemic sexually transmitted disease caused by the leptospira. The global pharmaceutical ... Read More